Stifel analyst Mark Astrachan raised the firm’s price target on Procter & Gamble to $161 from $157 and keeps a Hold rating on the shares. The firm anticipates fiscal Q4 organic sales growth similar to roughly 3% growth in Q3, reflecting solid volume growth in the large majority of markets, weakness in Mainland China that the firm expects to continue for an additional 1-2 quarters, and contribution from pricing also lessening, the analyst tells investors in a preview note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target raised to $174 from $170 at Barclays
- Procter & Gamble price target raised to $183 from $177 at Evercore ISI
- Procter & Gamble price target raised to $176 from $171 at Deutsche Bank
- Procter & Gamble price target raised to $190 from $177 at Citi
- Procter & Gamble Unveils Stock Market Investment Strategies
Questions or Comments about the article? Write to editor@tipranks.com